Oracle stock surges 5% as analysts see major upside ahead

Oracle stock surges 5% as analysts see major upside ahead
Ananthu C U
04 Sept 2026, 06:18 AM

powered by

Invezz
ORCL buy

Buy Oracle (ORCL). The stock is repricing toward a “growth phase” as OCI keeps outgrowing peers (93% constant-currency growth) and sentiment is near peak-negative. The setup is a likely upside surprise in cloud/SaaS mix and cash funding easing into fiscal 2027, with catalysts on Sept 8 earnings and Oct 28 analyst day.

Key Risk: OCI growth or margins disappoint, forcing Oracle to keep heavy capex and debt longer than expected.

ORCL sell into hype

Sell Oracle (ORCL) if it spikes further before Sept 8. The article shows big bullish targets ($325) but also very high capex ($95B in fiscal 2027) and financing needs ($40B). With Wall Street still split, the risk is a “buy the rumor” move that fades on any cautious guidance around AI spending and backlog-to-revenue conversion.

Key Risk: Management guides to sustained aggressive AI capex and slower backlog conversion, but the market still sells off—turning the pre-earnings run into a durable rerating down.

  • Oracle stock jumps 5% as analysts weigh its AI growth outlook.
  • Bernstein sees major upside as Oracle’s cloud growth accelerates.
  • Jefferies and TD Cowen cut targets but maintain Buy ratings.

Oracle stock ORCL surged 5% on Thursday, extending a 3% gain from the previous session as investors assessed a mixed set of analyst views ahead of the company’s fiscal first-quarter results.

Oracle is scheduled to report its results on September 8.

The stock has faced concerns over its heavy capital spending, debt levels and ability to finance long-term commitments tied to its artificial intelligence expansion.

However, some analysts believe the company could be approaching a more favorable phase as cloud growth accelerates and funding requirements begin to ease.

Bernstein sees Oracle entering growth phase

Bernstein analyst Mark Moerdler described Oracle as a complex and volatile business, with investor concerns centered on profitability and the cash needed to fund its long-term, noncancelable contract commitments.

Moerdler believes Oracle could be nearing the end of its need for additional cash and sees the company in the early stages of an investment phase that could accelerate both revenue and profits.

His $325 price target implies substantial upside from Oracle’s current share price of $145.30.

A key part of his bullish view is Oracle Cloud Infrastructure (OCI), which he said continues to outgrow major hyperscaler peers, including Microsoft’s Azure, Google’s cloud business and Amazon’s AWS.

Oracle reported 93% constant-currency growth for OCI in its latest fiscal fourth quarter.

Moerdler expects OCI growth to accelerate during fiscal 2027, with the segment growing faster year over year than Oracle’s overall revenue.

Analysts cut targets despite bullish views

Oracle’s aggressive AI expansion has also raised concerns about capital requirements.

The company plans to spend $95 billion on capital expenditures during fiscal 2027, which runs from June 1 through May 31.

Oracle raised $43 billion through debt financing in fiscal 2026 and expects to raise roughly $40 billion in fiscal 2027 through a combination of debt and equity.

Jefferies analyst Brent Thill lowered the firm’s price target to $290 from $320 while maintaining a Buy rating.

Jefferies said sentiment toward Oracle was near peak-negative and that much of the negative outlook may already be reflected in the stock.

Thill expects a potential growth inflection in Oracle’s cloud business and stronger software-as-a-service growth to challenge the bearish investment case.

TD Cowen also lowered its price target to $240 from $300 while retaining a Buy rating.

The firm identified Oracle’s analyst day on October 28 as the next major catalyst and expects the event to focus heavily on the cloud business and potentially include updated fiscal 2030 targets.

Cloud growth remains central to Oracle outlook

Oracle’s complex business structure has made it difficult for investors to assess its longer-term growth and profitability, particularly because its products and services are at different stages of maturity.

The company also has $638 billion in remaining performance obligations, or backlog, leaving investors focused on how quickly those commitments can be converted into revenue.

Moerdler’s thesis also depends on the changing composition of Oracle’s revenue.

Lower-growth areas such as its license business are declining, while higher-growth software-as-a-service businesses, including Fusion, NetSuite and OCI, are becoming a larger share of software revenue.

Oracle’s upcoming fiscal first-quarter results could provide investors with further insight into the pace of cloud growth, AI-related investment and the company’s ability to fund its expansion.

With analyst price targets ranging from $240 to $325 despite Buy or bullish ratings, Wall Street remains divided on the balance between Oracle’s growth opportunities and the financial demands of its AI expansion.